Skip to main content
. 2017 Aug 17;12(8):e0183306. doi: 10.1371/journal.pone.0183306

Table 5. Cost–effectiveness of childhood rotavirus vaccination, Norway, 2015–2019.

Perspective Cost–effectiveness outcome Rotarix®
Mean (€)
RotaTeq®
Mean (€)
Healthcare Cost per QALY loss avoided 47 447 52 709
Cost per case avoided 70 77
Cost per hospitalised case avoided 1150 1278
Societal Savings per QALY loss avoided 187 784 182 552
Savings per case avoided 275 268
Savings per hospitalised case avoided 4 553 4 426